• Release date: 11/25/2025

• Expiration date: 11/25/2028

• Estimated time to complete activity: 17.25 hours

• Jointly provided by Partners for Advancing Clinical Education (Partners) and CME Science

Educational Objectives

At the conclusion of this activity, participants should better be able to:

-Optimize imaging methods to reduce the number of false-positive mammography interpretations.

-Describe recent advances and techniques in breast imaging.

-Integrate information presented in this course into efforts to improve the imaging skills of the participants.

Faculty

Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP

-Vice Chair, Faculty Development, Division Chief, Breast Imaging
-Director, Breast Imaging Fellowship Program
-The University of Mississippi Medical Center, Jackson, Mississippi
-Professor, Department of Clinical Sciences
-The University of Houston Tilman J. Fertitta College of Medicine, Houston, Texas
-Professor, Depart of Diagnostic and Interventional Imaging
-The University of Texas Health McGovern Medical School, Houston, Texas

Debra M. Ikeda, MD, FACR, FSBI

-Professor of Radiology (Breast Imaging), Emerita
-Stanford University School of Medicine

Sunita Pal, MD

-Professor of Diagnostic Imaging, Clinical Educator
-The Warren Alpert Medical School of Brown University
-Director of Nuclear Medicine, The Miriam Hospital

Ray Cody Mayo, MD

-Associate Professor of Radiology
-Department of Breast Imaging
-University of Texas
-The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Uzma Waheed, MD

-Clinical Assistant Professor
-Department of Radiology
-Stanford University School of Medicine

Sarah Pittman, MD, FRCPC

-Clinical Associate Professor
-Department of Radiology
-Stanford University School of Medicine

Course Curriculum

Advanced Breast Imaging 2026

Advanced Breast Imaging 2026

  1. Review Breast Anatomy and Benign Breast Entities with Mammogram, Ultrasound and MRI Correlation - Sarah M. Pittman, MD, FRCPC
  2. Tomosynthesis Update 2025 - Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP
  3. Is Contrast Enhanced Mammography a Better Mammogram - Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP
  4. Calcifications - Ray Cody Mayo, MD
  5. BI-RADS 3 Dilemmas on Digital Mammography & Ultrasound - Avoiding Misinterpretation- Sunita Pal, MD
  6. Multimodality Radiology-Pathology Correlation For Elevated Risk Pathology - Sunita Pal, MD
  7. Tips on Improving Cancer Detection on Digital Mammography & Ultrasound Part 1 - Sunita Pal, MD
  8. Imaging After Breast Conservation Therapy - Sarah Pittman, MD, FRCPC
  9. Tips on Improving Cancer Detection on Digital Mammography & Ultrasound Part 2 - Sunita Pal, MD
  10. Simplifying Biopsies with Breast Ultrasound - Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP
  11. Breast Cancer Biology, Subtypes and Imaging Appearances - Uzma Waheed, MD
  12. Breast Cancer Staging with Ultrasound - Ray Cody Mayo, MD
  13. Challenging Breast US and US-Guided Biopsy - Debra Ikeda, MD, FACR, FSBI
  14. Targeted Axillary Dissection -History and Updates - Ray Cody Mayo, MD
  15. Breast Cancer Localization- No More Wires! - Mammography and Ultrasound - Ray Cody Mayo, MD
  16. Breast MRI - Approach and Cases - Ray Cody Mayo, MD
  17. Abbreviated MRI and Novel Breast Imaging Modalities - Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP
  18. MRI-Guided Breast Biopsies - Tanya Moseley, MD, DBA, FACR, FSBI, PMP, CMQ/OE, CN-BP
  19. Between a Rock and a Hard Place on Steotactic Biopsy and Localizations - Debra Ikeda, MD, FACR, FSBI
  20. BI-RADS 3 Probably Benign - Ray Cody Mayo, MD
  21. Challenging Calcification Cases on Digital Mammography - Sunita Pal, MD
  22. Pitfalls in Review of Outside Films (Mammo_US_MRI_CEM) including Post-Cryoablation - Debra Ikeda, MD, FACR, FSBI
  23. Update on Digital Breast Tomosynthesis and Digital Mammography with AI - Debra Ikeda, MD, FACR, FSBI
  24. IMPORTANT: HOW TO CLAIM YOUR CME

Pricing

$1,499.00 USD
Advanced Breast Imaging 2026
17.25 AMA PRA Category 1 Credit(s)™

Enroll Now

Refund Policy: Cancellation and refund requests must be made within 24 hours of purchase. Within the first 24 hours you may cancel and be refunded the full amount of the purchase , less a $100.00 administrative fee. After 24 hours no refunds will be allowed.

Please note: If you have applied for CME credit during this period “NO” refunds will be available.

 

Important Notice Regarding Copyright and Usage

All materials purchased from CME Science are protected by copyright and are for the sole personal use of the purchaser.

 

Distributing, forwarding, transferring, reproducing, or reselling these educational materials in any way is strictly prohibited and constitutes copyright infringement. This includes, but is not limited to, sharing them with others, posting them online, or incorporating them into other products or services.

 

Your license to access these materials is non-transferable and applies only to you, the original purchaser.

 

We reserve the right to terminate or restrict your access to our service, without prior notice, if we find any violation of these terms and conditions.

JA

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Partners for Advancing Clinical Education (Partners) and CME Science. Partners for Advancing Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Partners for Advancing Clinical Education (Partners) designates this enduring material for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosure of Conflicts of Interest

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

  • Dr. Tanya Moseley, faculty for this activity, has no relevant financial relationships.
  • Dr. Debra M. Ikeda, faculty for this activity, has no relevant financial relationships.
  • Dr. Sunita Pal, faculty for this activity, has no relevant financial relationships.
  • Dr. Ray Cody Mayo, faculty for this activity, has no relevant financial relationships.
  • Dr. Uzma Waheed, faculty for this activity, has no relevant financial relationships.
  • Dr. Sarah Pittman, faculty for this activity, has no relevant financial relationships.

Media

Internet

Computer System Requirements

Any internet accessible device.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

For additional information about the accreditation of this activity, please visit https://partnersed.com